Argus Cuts MetLife's Target From $62 To $54, Stock Still A Buy

By: via Benzinga
Argus’ Jacob Kilstein reiterated a Buy rating on Metlife Inc (NYSE: MET), while lowering the price target from $62 to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.